Susquehanna International Group, LLP Applied Therapeutics Inc. Call Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$4.35 - $8.5 $697,305 - $1.36 Million	160,300 Added 55.6%	448,600 $3.81 Million
Q2 2024 Aug 15, 2024	SELL	$4.04 - $6.37 $1.9 Million - $3 Million	-470,400 Reduced 62.0%	288,300 $1.35 Million
Q1 2024 May 07, 2024	BUY	$2.25 - $7.4 $1.52 Million - $4.99 Million	674,600 Added 802.14%	758,700 $5.16 Million
Q4 2023 Feb 14, 2024	SELL	$1.84 - $3.35 $423,384 - $770,835	-230,100 Reduced 73.23%	84,100 $281,000
Q3 2023 Nov 14, 2023	BUY	$1.26 - $2.77 $395,892 - $870,334	314,200 New	314,200 $782,000
Q2 2022 Aug 15, 2022	SELL	$0.76 - $2.64 $29,868 - $103,752	-39,300 Reduced 74.71%	13,300 $13,000
Q3 2021 Nov 15, 2021	BUY	$13.54 - $22.06 $444,112 - $723,568	32,800 Added 165.66%	52,600 $873,000
Q2 2021 Aug 11, 2021	BUY	$14.05 - $25.04 $278,190 - $495,792	19,800 New	19,800 $411,000

140

112M

1.68M

1.91M

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $43.7M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.